Literature DB >> 8000382

Uptake of liposomes surface-modified with glycyrrhizin by primary cultured rat hepatocytes.

S Osaka1, H Tsuji, H Kiwada.   

Abstract

Previously, we synthesized 30-stearyl glycyrrhizin (GLOSt) and reported that small unilamellar liposomes containing GLOSt (GLOSt-SUV) accumulated in the liver several times more than the control liposomes (control-SUV). In the present study, to determine the interaction between GLOSt-SUV and hepatocytes, in vitro uptake experiments were achieved with primary cultured rat hepatocytes. The uptake amount of GLOSt-SUV by rat hepatocytes was considerably higher compared to the control-SUV, while GLOSt-SUV showed about a 10-fold higher uptake level than the control-SUV during 2 h of incubation. It was assumed that GLOSt-SUV not only bind to the surface of the hepatocytes but are internalized and degraded in the cells, because at 37 degrees C, GLOSt-SUV were taken up and the level of the degradable marker was lower than the inert marker, and this did not occur at 4 degrees C. Since the uptake of GLOSt-SUV was inhibited by glycyrrhizin (GL), it was suggested that a binding-site for GL is present on the surface of hepatocytes, and GLOSt-SUV are likely to be internalized via this site by the hepatocytes. Furthermore, it was confirmed that the efficacy of GLOSt on liposomes is not affected by the fluidity of the liposomal membrane.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8000382     DOI: 10.1248/bpb.17.940

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  5 in total

1.  Uptake of albumin nanoparticle surface modified with glycyrrhizin by primary cultured rat hepatocytes.

Authors:  Sheng-Jun Mao; Shi-Xiang Hou; Ru He; Liang-Ke Zhang; Da-Peng Wei; Yue-Qi Bi; Hui Jin
Journal:  World J Gastroenterol       Date:  2005-05-28       Impact factor: 5.742

2.  Pharmacokinetic profile of ABELCET (amphotericin B lipid complex injection): combined experience from phase I and phase II studies.

Authors:  A Adedoyin; J F Bernardo; C E Swenson; L E Bolsack; G Horwith; S DeWit; E Kelly; J Klasterksy; J P Sculier; D DeValeriola; E Anaissie; G Lopez-Berestein; A Llanos-Cuentas; A Boyle; R A Branch
Journal:  Antimicrob Agents Chemother       Date:  1997-10       Impact factor: 5.191

3.  Antitumor activities of novel glycyrrhetinic acid-modified curcumin-loaded cationic liposomes in vitro and in H22 tumor-bearing mice.

Authors:  Mingxiang Chang; Meimei Wu; Hanmin Li
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419

4.  Preparation of 10-hydroxycamptothecin-loaded glycyrrhizic acid-conjugated bovine serum albumin nanoparticles for hepatocellular carcinoma-targeted drug delivery.

Authors:  Yuangang Zu; Li Meng; Xiuhua Zhao; Yunlong Ge; Xinyang Yu; Yin Zhang; Yiping Deng
Journal:  Int J Nanomedicine       Date:  2013-03-27

5.  Synthesis and characterization of glycyrrhizin-decorated graphene oxide for hepatocyte-targeted delivery.

Authors:  Zonghua Wang; Yanli Gao; Jianfei Xia; Feifei Zhang; Yanzhi Xia; Yanhui Li
Journal:  C R Chim       Date:  2012-06-25       Impact factor: 3.117

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.